Table of contents
At a glance
How do you validate Dynamics 365 Finance and Operations for GMP use?
Validate the Finance and Supply Chain Management processes actually used according to their impact on quality and data. Trace which quantities are inspected, blocked, planned and allowed for subsequent use. Link requirements, configuration, roles and interfaces to positive and failure tests. A passed quality order or successful financial posting does not replace system validation or a required pharmaceutical release.
- Finance, Supply Chain Management, Enhancements, and Deployment constitute the specific system scope.
- The sample quantity, blocked quantity, and available inventory level shall be evaluated separately.
- A status name alone is insufficient: what is decisive is the actually permitted actions.
- Updates are evaluated against affected processes and remaining gaps in substantiation.
Define and scope finance and supply chain management appropriately
Finance and Operations refers to the overarching application context. Microsoft currently offers Dynamics 365 Finance and Dynamics 365 Supply Chain Management as separate applications. Financial accounting, creditors, and budgeting fall under Finance; the quality and inventory functions discussed here originate from Supply Chain Management. A Business Central guide does not constitute a reliable functional specification.
Capture application and build, activated features, organizations, locations, enhancements, inventory concept, and interfaces. Clarify the actual deployment and operational responsibility. A general cloud statement neither proves which modules are licensed nor which enhancements were installed by an implementation partner. Furthermore, an unused module does not require the same level of scrutiny as a critical material decision, solely due to its existence.
The regulatory basis for this article pertains to the use within the GMP manufacturing of human medicinal products. The current EudraLex overview designates Annex 11, as revised in January 2011, for this context. The specific quality and data impact determines the scope of validation. Pure financial functions are not automatically considered GMP functions; however, shared data or permissions may still be relevant. Other regulatory areas must be evaluated separately.
Assign decisions and documentation accurately and clearly.
Before test planning, clearly define what each status means in a professional context. Can a material be planned, reserved, issued, or actually used? Which decision originates from the laboratory and which from the responsible quality function? The following work aid addresses these questions; it is not a prescribed document format and does not represent a universal Microsoft configuration.
A complete record must include the relevant identity: article, batch, quantity, unit, company, and pertinent storage dimensions. A screenshot with green status lacking this assignment may conceal a critical misapplication. Additionally, document allowable exceptions, such as an internal movement for sampling, even if its use in manufacturing is not yet authorized.
| Decision | Technical Reference | What the test should differentiate |
|---|---|---|
| Arrange a review | Quality Assignment and Quality Responsibility | Correct trigger, test scope and batch; not just an existing job. |
| protect quantity | Stock block and sampling configuration | Sampled subset relative to the entire protected quantity. |
| Allow follow-up action | Batch disposition, planning and storage workflow | Reservation, withdrawal and dispatch according to agreed target. |
| Post the business transaction | Finance/SCM document and process event | Commercial closure in contrast to an independent quality decision. |
| Release of finished pharmaceutical product batch | Fixed release procedure with QP involvement | Certification required instead of mere availability of stock. |
Distinguish the quantity inspected from the quantity blocked
Quality assignments can trigger quality tasks at defined business events. Therefore, verify the condition itself: Does it apply to the correct item, location, delivery process, and time point? A successful test of a goods receipt does not automatically demonstrate coverage for a second location or a different entry point. Use a relevant and a closely adjacent case, and one slightly outside the defined scope.
Microsoft distinguishes regarding blocking effects between manually and automatically generated quality tasks. In manual creation, the order quantity determines the blocked quantity; a sample does not automatically adjust this protection scope. In automated generation, full blocking can protect the entire source quantity. The option "Create item sampling work only" generates neither a quality task nor a stock block. Exactly these variants should be included in the configuration assessment.
Define separate target values for the sample quantity and protected quantity. Additionally, monitor the exception pathway: Is it permitted for an employee to establish a manual instruction instead of the intended automated process? If yes, what control ensures the remaining inventory is protected? A purely organizational note is only viable if its implementation, responsibility, and effectiveness are aligned with the specific risk involved.
Check the batch disposition against the authorized action
Batch disposition codes can influence availability and individual follow-up actions. Microsoft documents for "Unavailable" initial blocking instructions, but also allows for adjustable exceptions. Therefore, the designation "not available" is insufficient as a test result. Nettable determines whether inventory is considered in the planning phase. A planned quantity addresses a different question than the possibility of withdrawal.
Verify the actually used sales, transfer, and production routes. For WMS items, warehouse configuration and reservation hierarchy are also relevant; the manufacturer documentation specifies the exact prerequisites. A test outside your operational warehouse concept may confirm a lock that behaves differently in subsequent operations. Ensure that key test and production parameters are comparable and justify any deviations.
With combined locking mechanisms, multiple bookings may reference the same physical inventory. Therefore, do not blindly sum the displayed locked quantities. Compare physical quantity, professional availability, reservations, and the origin of each lock. If controlled internal movement is permitted despite quarantine, explicitly test this separately from unauthorized use or distribution.
Sample test with independently calculated required quantities
The following example does not represent a completed product test. A material has Batch R with 80 usable units. Batch Q is added with 200 units and remains fully locked until the intended quality decision is made. Ten units are non-destructively inspected and remain physically part of the 200. The requirement is for 110 units. This sample size is a hypothetical assumption, not a professional sampling recommendation.
Thus, 280 units are physically available upon release, but only 80 are available for the defined intended use. A shortfall of 30 usable units exists. Following a justified positive decision, in the example 80 units from R and 30 units from Q may be used; Q then contains 170 units. Negative branches initiate again from the defined initial state, ensuring that erroneous bookings do not compromise subsequent outcomes.
| Test case | Input or modification | Independently established expected result | Supporting record |
|---|---|---|---|
| Starting point | R: 80 available; Q: 200 locked; Requirement: 110 | Physical 280; available 80; not covered 30. | Batch and dimension reference and available quantity. |
| Automated Test Instruction | 10 test units; complete blocking of source quantity | 10 verified, further 200 from Q protected. | Order type, parameters, and actual usage verification. |
| False manual bypass route | Only 10 units as a manual order quantity | The remaining 190 must not be inadvertently usable; otherwise, investigation shall be conducted. | Effective additional control or reproducible protection gap. |
| Authorized Quality Decision | Q released for the defined mode of use | 280 usable prior to consumption; 80 from R plus 30 from Q totals 110. | Decision basis, authorized role, and permitted action. |
| Usage after release | Use 80 from R and 30 from Q. | R: 0; Q: 170; Total inventory: 170. | Records showing the quantities and the correct batch. |
| A change that is not permitted | Unauthorised role tries to change Q stock to available | No effective change implemented; verify authorities and change justification. | Error message or deviating actual result. |
Results, analysis certificate, and pharmaceutical decision are separated
A quality instruction may collect inspection results and indicate a positive closure. Microsoft simultaneously logs the re-opening of an already validated instruction. Therefore, define what a subsequent change entails regarding a previously made material decision. If the existing batch remains usable, is the decision reviewed or does another control take precedence? This question must be addressed in accordance with your risk assessment.
An analytical certificate is a deliberately compiled report. The inclusion of individual tests is configurable. Therefore, compare the required report against the actual underlying results, units, and test versions. The absence of a test must not go unnoticed simply because the report formally appears complete. Document who is authorized to modify a report selection and how a relevant change is evaluated.
For finished pharmaceutical products, Annex 16 distinguishes between the testing, QP certification, and the subsequent transition into marketable inventory. A material release in the ERP does not automatically constitute this certification. Define, for interconnected systems, which evidence triggers a technical status change and how a revoked or corrected decision affects subsequent usage.
Test interfaces at the subject matter transition point
For a quality decision from a LIMS or QMS, it is not only the technical transmission that is important. As a test specification, the message should clearly refer to company, article, batch and permissible status changes. Define which system is leading and what happens if this assignment is missing. An accepted message without technically effective assignment is not a successful overall process.
Build appropriate failure scenarios: send the same decision twice, query an unknown batch, deliver an older decision after a newer one, or interrupt processing. The expected behavior depends on the selected interface. Neither assert blanket synchronization nor automatic duplicate safeguarding. Verify the actual target state and the ability to detect an incomplete transition and subsequently review and correct it.
During migrations, the significance of data volume is equally important. Transferred lock keys, batch identities, and open quality tasks must not operate differently without explicit documentation or justification. Compare selected critical data sets against an independent source and subsequently evaluate the permitted actions. A simple volume summation would fail to explain the discrepancy between 280 physical units and 80 usable units in the example.
Make rights and relevant changes traceable
Develop a concise decision matrix for material receipt, result evaluation, status update, parameter maintenance, and technical administration. The names of the roles are secondary; what matters is which combinations are actually feasible. Consider standing-in provisions and technical interface accounts. A user without a visible menu point may still intervene through an alternative designated write pathway.
Review a justified change and the same trial with insufficient authorization. Additionally, address a change to a quality-related rule: Properly secured batches offer little protection if the same individual can inadvertently disable the lockout condition without detection. Document the actually effective control, rather than inferring completeness from a job title alone.
For relevant changes, the previous and current situations, responsibility, timing, and, if applicable, rationale are required. It must be assessed which records your specific environment provides; this guide does not claim a universal Dynamics audit scope. Define who evaluates these records in case of discrepancies and how they remain traceable in relation to quality instructions and material decisions.
Evaluate updates based on impact rather than calendar perception
The One-Version process integrates application and platform changes; certain add-on components follow separate update pathways. Therefore, in addition to the main build, capture the affected extensions and associated services. Microsoft outlines different workflows for cloud and on-premise deployments. Plan based on your actual service process; historical version examples do not constitute current release approval.
Select regression based on a specific chain of effects: Could the change affect the trigger of the quality order, the blocking quantity, a storage action, permission or interface assignment? Then, corresponding existing evidence and if necessary retests are included in the evaluation. Also an unchanged function may be affected. Conversely, an update does not automatically justify the repetition of all tests ever performed.
The Microsoft documentation describes testing tools and repeatable business processes. A technically successful automated run must still verify the correct expectations. Therefore, maintain test data, parameters, and result comparisons under controlled review. Preview functions, such as explicitly labeled as "Preview" quality assignments, must not be silently considered as valid production controls in your release justification.
What your team should assemble prior to validation
QA should define the significance of quality decisions and unauthorized usages. Warehouse and production teams demonstrate actual booking and exception pathways. IT and implementation partners provide details on configuration, integration, and operation. Finance evaluates the associated financial implications. These contributions do not need to arise in separate projects, but should reference the same clearly defined process and system state.
The effort increases significantly, particularly when multiple companies are involved, divergent warehousing concepts, unclear legacy parameters, individual customizations, and the absence of a test environment. A reliable preparation begins with a critical material flow—including its exceptions. Thereafter, it can be determined which variants require individual testing and which are adequately covered by transparent, shared evidence.
- Applications, build, feature status, hosting, and responsible party documented.
- Sample quantity, blocked quantity, and allowable follow-up actions separately defined.
- Automated triggers and manual backup procedures are recorded.
- Batch, company, and warehouse dimensions in test data are uniquely defined.
- Quality decision, report, and, if applicable, reference to QP.
- Roles and technical documentation with negative cases reviewed.
- Evaluation of interface errors and retry actions based on the target state.
- Findings, residual gaps, operating procedures, and update responsibility are determined.
Project experience and collaboration
Reconcile inspected, blocked and available quantities
For a concrete transaction, Quality and Logistics establish how much stock is inspected, how much remains blocked and how much may be used afterwards. IT and the partners show how Finance and Supply Chain Management implement those rules. Individual configured transitions may allow focused testing. Several disposition paths or interfaces require review of their interaction first. We compare quantities, permitted actions and the responsible business decision against independently established expectations.
Frequent Questions on Dynamics 365 and Inventory Decisions
Is Dynamics 365 Finance the same as Finance and Operations?
No. Finance is one of the current applications within the end-to-end Finance-and-Operations context. The quality tasks, restrictions, and batch allocations described herein originate from Supply Chain Management. Therefore, identify your actual applications and expansions. A standalone finance project does not inherently include all the described warehouse functions merely due to its name. For validation scope, the actual process chain in use is relevant, not the abbreviated designation on a quotation sheet.
Must all financial functions of a pharmaceutical company be validated?
The company's objective does not automatically classify every financial function as a GMP function. Assess its specific impact on product quality, relevant data, and process control. A simple budget analysis may be treated differently than a shared master data management function that alters material identities. Document this distinction and consider common technical controls. This results in a clear, justifiable scope rather than a one-size-fits-all full validation or equally blanket exclusion.
Does a quality release order always block the entire shipment?
No, this depends among other factors on the equipment route, order volume, and sampling/blocking configuration. For manual setups, the quality order volume determines the amount to be blocked. In automated production, full blocking can capture the entire source volume. Therefore, compare the actual protected volume with the expected volume and consider alternative, permissible uses. The existence of an existing order alone does not answer this question.
Sources: [5]
Does a sample take instruction suffice as evidence of inventory hold?
No. In particular, Create item sampling work, according to Microsoft, neither generates a quality release order nor imposes a stock lock. Therefore, an order for a physical sample movement does not necessarily indicate that the remaining inventory is protected. Clarify which mechanism is responsible for performing this function. The test should evaluate both authorized sample withdrawal and unauthorized use of the remaining inventory, and provide evidence of the applicable control in place.
Sources: [3]
Why must Unavailable be tested for multiple actions?
Since the batch disposition supports configurable exceptions and different action types, and the execution within the WMS context may depend on the reservation hierarchy and warehouse configuration, verify each used reservation, withdrawal, and dispatch activity against your requirements. Controlled movement for investigation purposes may be permissible, while production usage remains locked. The status name does not replace this technical distinction.
Sources: [6]
Is the validation of a quality instruction considered a computerized system validation?
No. The product-internal completion of a quality order assesses a specific test subject based on the installed functions. Computer system validation, however, concerns the suitability of the intended system use, including configuration, data paths and controls. The QP certification of a pre-filled drug batch also has its own professional and regulatory purpose. Make these decisions clearly in specifications and tests so that a positive software status should not replace several different evidence.
What should be verified upon re-opening a quality task?
First, determine who is authorized to use this pathway and which prior decisions may be affected. Following this, assess the impact of result modifications, conduct a renewed evaluation, and evaluate the effect on available inventory or associated systems. The mere presence of a reopen function is neither a defect nor sufficient control. A clear, traceable procedure is required that maintains the prior decision status, the change, and its subsequent application.
Does a successful interface import suffice for the release test?
No. Additionally, compare whether the correct batch is in the correct company and has obtained the appropriate status, and whether a follow-up action is permitted or blocked. A duplicate or delayed message should not inadvertently override a more recent decision without notice. The technical feasibility of error handling depends on your integration. Define the intended outcome in advance and ensure both source documentation and target outcome are verified.
How much regression testing is required for a Dynamics update?
To the extent that a justified impact assessment and existing evidence are required. Focus on affected quality triggers, locks, authorizations, reports, and data transfers. Also evaluate indirectly impacted, unchanged functions. A vendor service update does not validate your entire process; likewise, a full retest is not automatically required after every change. Your actual release and update process determines the available preparation, not a general project assumption.
What causes the highest preparation burden in a smaller company?
The key question is whether an individual can provide a binding explanation of the actually operated material flow, including exceptions. Appropriate test data, contact points from Quality and Storage, and access to configuration and integration documentation are required. Multiple companies, individual enhancements, and inconsistent status definitions increase the need for clarification. A fixed duration cannot be reliably derived from this. Start with a critical workflow and then determine the necessary coverage of variants.
Sources and review date
Source date: 6 October 2026. Manufacturer functions refer to the linked finance/SCM documentation; Build, features, licenses, and deployment are to be verified against your environment. Regulatory reference: GMP for human medicinal products. Examples and review suggestions are standalone reference materials, not completed product testing.
- Finance and operations application documentation
- Welcome to Dynamics 365 Finance
- Quality associations
- Quality orders
- Inventory blocking
- Use batch disposition codes to mark batches as available or unavailable
- One Version service updates FAQ
- EudraLex Volume 4 – Human Medicinal Products – GMP
- EU GMP Annex 11: Computerised Systems
- EU GMP Chapter 4: Documentation
- EU GMP Annex 16: Certification by a Qualified Person and Batch Release
Sources checked: .
Ensure traceability of quality decisions in Dynamics
Daniel Herrmann Consulting supports you in defining the relevant finance/SCM scope and linking existing evidence to actual material and data pathways.
- Computer system validation →
Bring your GxP systems into validated operation, from laboratory software, MES and eQMS to ERP. We define the scope, plan risk-based tests using GAMP 5 and hand the evidence to QA for release.

